Obstetrics and Gynecology

Volume 90%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Seek %0-9
00:00
00:00
00:00
 

Chapters

Transcript

Video

Trial 20-153: SACI-IO for Hormone Receptor Positive Metastatic Breast Cancer

Why test the combination of Trodelvy and pembrolizumab? Previous efforts testing immunotherapy for HR+ breast cancer has shown disappointing results.

Related Presenters

Filipa Lynce, MD.

Filipa Lynce, MD

Medical Oncology

View Profile

ADVERTISEMENT

Related Videos

Updated Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Clinical Trials Video

Updated Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Clinical Trials

Study of SACI-IO for Triple Negative Metastatic Breast Cancer Video

Study of SACI-IO for Triple Negative Metastatic Breast Cancer